EBR Systems, a leading innovator in wireless heart stimulation, has received European CE Mark for its WiSE (Wireless Stimulation Endocardially) Technology.
According to the company, EBR Systems' WiSE Technology is the world's only wireless endocardial pacing system for cardiac resynchronization therapy (CRT).
Kokilaben Hospital Reaches a Milestone With 5,000 Successful Pediatric Cardiac Surgeries
The Children's Heart Center is said to be the only integrated facility for treating congenital heart disease in Mumbai and Western India.
Advertisement
CE Mark approval gives EBR Systems the ability to train and educate physicians in the European Union on the use of the WiSE System. It will help more patients to benefit from this innovative therapy.
Preliminary results of the recently completed SELECT-LV study were presented in mid-May by Mt. Sinai Hospital cardiologist and Professor of Medicine Vivek Reddy, M.D., at the Heart Rhythm Society Scientific Sessions in Boston.
![35 Minutes Of CPR For Out-Of-Hospital Cardiac Arrest can Help Achieve Favorable Results]( "35 Minutes Of CPR For Out-Of-Hospital Cardiac Arrest can Help Achieve Favorable Results")
The study in more than 17 000 patients found that nearly all survivals were achieved within 35 minutes and longer CPR achieved little benefit.
The results were highly positive. "A growing body of evidence strongly suggests EBR's WiSE Technology can benefit patients who have failed conventional cardiac resynchronization implants," said EBR Systems CEO Allan Will. "We look forward to working with leaders in the European clinical community to further characterize the benefits of wireless endocardial pacing."
The WiSE Technology is leadless, completely eliminating the want for a pacing wire in the left ventricle. The technology consists of a tiny electrode implanted in the left ventricle. With every heartbeat it gets a synchronized ultrasound signal from a small transmitter placed between two ribs. Those sound waves are converted to electrical energy, providing cardiac pacing.
Source: Medindia
35 Minutes Of CPR For Out-Of-Hospital Cardiac Arrest can Help Achieve Favorable Results
The study in more than 17 000 patients found that nearly all survivals were achieved within 35 minutes and longer CPR achieved little benefit.
Advertisement
The results were highly positive. "A growing body of evidence strongly suggests EBR's WiSE Technology can benefit patients who have failed conventional cardiac resynchronization implants," said EBR Systems CEO Allan Will. "We look forward to working with leaders in the European clinical community to further characterize the benefits of wireless endocardial pacing."
The WiSE Technology is leadless, completely eliminating the want for a pacing wire in the left ventricle. The technology consists of a tiny electrode implanted in the left ventricle. With every heartbeat it gets a synchronized ultrasound signal from a small transmitter placed between two ribs. Those sound waves are converted to electrical energy, providing cardiac pacing.
Source: Medindia
Doctors are in Favor of Traditional Cardiac Surgery Despite Better Alternative
The chances of a re-surgery significantly comes down to less than 3% cases and less than 5% cases in 10 and 20 years time respectively if the surgeon opts for BIMA grafting.
Advertisement
 Biotronik’s BioMonitor 2 Implantable Wireless Cardiac Monitor Receives CE ApprovalThe device is designed for highly accurate and reliable long-term continuous remote monitoring of patients with atrial fibrillation, syncope and bradycardia. | Advertisement
|
Advertisement
Recommended Reading
Latest Medical Gadgets
Is it the flu or COVID-19? A new sensor can tell you whether you are positive for flu or COVID-19 in 10 seconds.
A novel type of neural implant was found to restore limb function to amputees. The implant sheds insights into brain-machine interfaces.
The wearable sensor for muscle atrophy, the muscle condition can be used by an astronaut on a long mission to keep track of his health.
Newly developed custom 3D-printed heart replicas look and pump just like real human heart.
What is the market size for surgical robotics? The market size is expected to expand at a compound annual growth rate (CAGR) of 18.0% from 2023 to 2030.